|
rs4806073
|
HPN;HPN-AS1
|
Serum albumin measurement
|
C |
0.800 |
GeneticVariation |
GWASDB |
Discovery and fine mapping of serum protein loci through transethnic meta-analysis.
|
23022100 |
2012 |
|
rs4806073
|
HPN;HPN-AS1
|
Serum albumin measurement
|
C |
0.800 |
GeneticVariation |
GWASCAT |
Discovery and fine mapping of serum protein loci through transethnic meta-analysis.
|
23022100 |
2012 |
|
rs149131600
|
HPN;HPN-AS1
|
Diabetes
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria.
|
31511532 |
2019 |
|
rs149131600
|
HPN;HPN-AS1
|
Diabetes Mellitus
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria.
|
31511532 |
2019 |
|
rs2452000
|
HPN;HPN-AS1
|
Body Height
|
|
0.700 |
GeneticVariation |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
rs10406943
|
HPN;HPN-AS1
|
Blood Protein Measurement
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases.
|
29403010 |
2018 |
|
rs138450474
|
HPN;SCN1B
|
Epilepsy, Rolandic
|
C |
0.700 |
CausalMutation |
CLINVAR |
Exome-wide analysis of mutational burden in patients with typical and atypical Rolandic epilepsy.
|
29358611 |
2018 |
|
rs1688043
|
HPN;HPN-AS1
|
Serum albumin measurement
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases.
|
29403010 |
2018 |
|
rs1688043
|
HPN;HPN-AS1
|
C-reactive protein measurement
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Bivariate genome-wide association study identifies novel pleiotropic loci for lipids and inflammation.
|
27286809 |
2016 |
|
rs1688043
|
HPN;HPN-AS1
|
Triglycerides measurement
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Bivariate genome-wide association study identifies novel pleiotropic loci for lipids and inflammation.
|
27286809 |
2016 |
|
rs4806073
|
HPN;HPN-AS1
|
Serum albumin level
|
C |
0.700 |
GeneticVariation |
GWASDB |
Discovery and fine mapping of serum protein loci through transethnic meta-analysis.
|
23022100 |
2012 |
|
rs72550247
|
HPN;SCN1B
|
ATRIAL FIBRILLATION, FAMILIAL, 13
|
|
0.700 |
GeneticVariation |
UNIPROT |
Mutations in sodium channel β1- and β2-subunits associated with atrial fibrillation.
|
19808477 |
2009 |
|
rs2305745
|
HPN;HPN-AS1
|
Malignant neoplasm of prostate
|
|
0.010 |
GeneticVariation |
BEFREE |
The statistical analysis suggested that three SNPs (rs45512696, rs2305745, rs2305747) were significantly associated with the risk of prostate cancer (odds ratio (OR)=2.22, P=0.04; OR=0.73, P=0.03; OR=0.76, P=0.05, respectively).
|
22665141 |
2012 |
|
rs2305745
|
HPN;HPN-AS1
|
Prostate carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
The statistical analysis suggested that three SNPs (rs45512696, rs2305745, rs2305747) were significantly associated with the risk of prostate cancer (odds ratio (OR)=2.22, P=0.04; OR=0.73, P=0.03; OR=0.76, P=0.05, respectively).
|
22665141 |
2012 |
|
rs2305747
|
HPN;HPN-AS1
|
Malignant neoplasm of prostate
|
|
0.010 |
GeneticVariation |
BEFREE |
The statistical analysis suggested that three SNPs (rs45512696, rs2305745, rs2305747) were significantly associated with the risk of prostate cancer (odds ratio (OR)=2.22, P=0.04; OR=0.73, P=0.03; OR=0.76, P=0.05, respectively).
|
22665141 |
2012 |
|
rs2305747
|
HPN;HPN-AS1
|
Prostate carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
The statistical analysis suggested that three SNPs (rs45512696, rs2305745, rs2305747) were significantly associated with the risk of prostate cancer (odds ratio (OR)=2.22, P=0.04; OR=0.73, P=0.03; OR=0.76, P=0.05, respectively).
|
22665141 |
2012 |
|
rs72550247
|
HPN;SCN1B
|
Atrial Fibrillation
|
|
0.010 |
GeneticVariation |
BEFREE |
We identified 2 nonsynonymous variants in SCN1B (resulting in R85H, D153N) and 2 in SCN2B (R28Q, R28W) in patients with AF.
|
19808477 |
2009 |